SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-05-000244
Filing Date
2005-08-12
Accepted
2005-08-12 16:26:07
Documents
9
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q DATED (6-30-2005) a11250e10vq.htm 10-Q 363931
2 EXHIBIT 4.23 a11250exv4w23.txt EX-4.23 148531
3 EXHIBIT 4.24 a11250exv4w24.txt EX-4.24 29289
4 EXHIBIT 4.25 a11250exv4w25.txt EX-4.25 40850
5 EXHIBIT 4.26 a11250exv4w26.txt EX-4.26 42287
6 EXHIBIT 4.27 a11250exv4w27.txt EX-4.27 37482
7 EXHIBIT 31.1 a11250exv31w1.txt EX-31.1 3412
8 EXHIBIT 31.2 a11250exv31w2.txt EX-31.2 3495
9 EXHIBIT 32.1 a11250exv32w1.txt EX-32.1 2173
  Complete submission text file 0000936392-05-000244.txt   673050
Mailing Address 6725 MESA RIDGE ROAD SUITE 100 SAN DIEGO CA 92131
Business Address 6725 MESA RIDGE ROAD SUITE 100 SAN DIEGO CA 92131 8585520866
ADVENTRX PHARMACEUTICALS INC (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 051022046
SIC: 2834 Pharmaceutical Preparations